← All trials
NCT02670772
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2012
- Primary completion
- Dec 1, 2014
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 1077
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Willem Daniel Francois VenterLead sponsor
- Wits UniversityOverall official - principal investigator
- Bill and Melinda Gates FoundationCollaborator
- University of the WitwatersrandSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.